A number of writers and Wall Street pundits have been surprised that Wyeth today named Bernard Poussot its new CEO, starting January 1, 2008.
The WSJ Health Blog wrote, "In a surprise, Wyeth said today that Bernard Poussot (pictured) will take over as CEO starting on Jan. 1 of next year. He’ll be replacing current CEO Robert Essner, who’s only 59."
Pharmalot wrote, "it will be interesting to see if he has any new ideas about transforming Wyeth - or if he’ll just sell the company."
Bloomberg News wrote, "The change came ``faster than people had thought,'' said Michael Krensavage, an analyst with Raymond James and Associates Inc. in New York, in a telephone interview today. ``I wasn't expecting it this early. I think the shareholders are frustrated with the string of pipeline setbacks.'' "
and
"Bernard Poussot, having been president and COO, was the heir apparent,'' said Lehman Brothers analyst Tony Butler in a telephone interview. ``But the timing of the announcement is a bit of a surprise."
Philly.Inc wrote "That was a bit faster than expected."
So, everyone is surprised. What is interesting is also that Wyeth announced only a few months ago that CFO and vice chairman Ken Martin would "leave the company to pursue personal interests at the end of June."
So what's up over at Wyeth? Normally CEO's don't just hand over the reins voluntarily and CFO's don't take up personal interests.
I can't help but wonder if the explanation is right there in my article Pfizer should buy Wyeth. Here's why.

Flonase is a nasal corticosteroid that works directly on nasal tissue to reduce swelling and inflammation. The medication is used to treat itching, runny nose, postnasal drip, nasal congestion and sneezing in people with a history of rhinitis.
http://www.drugs-generic.info/index.php?prod=Flonase
Silgulair is a prescription medicine approved to help control asthma in adults and children as young as 12 months and to help relieve the symptoms of seasonal allergies in adults and children as young as 2 years. Singulair will not replace fast-acting inhalers for sudden symptoms. You should still have rescue medication available and continue to take your other asthma medications unless your doctor tells you to stop. For asthma, Singulair should be taken once a day, in the evening as prescribed, whether or not you have asthma symptoms. If your symptoms get worse or you need to increase the use of your rescue inhaler, call your doctor at once.
http://www.drugs-generic.info/index.php?prod=Singulair
Posted by: allergy relief medicines | July 19, 2008 at 04:24 AM